United Therapeutics Corporation (UTHR) Insider Trading

Total insider buys:
  • $999,400.80
Total insider sells:
  • $834,836,763.10
Most recent insider trade:
  • April 17, 2025
Most active insider trader:
  • Martine A Rothblatt
Trader NameDateTitleAmountPriceTypeTotal Value
Aug. 3, 2017CEO1,248$126.41Sell$157,759.68
July 27, 2017CEO1,247$126.40Sell$157,620.80
July 20, 2017CEO1,236$131.62Sell$162,682.32
July 13, 2017CEO1,238$130.44Sell$161,484.72
July 6, 2017CEO1,234$132.29Sell$163,245.86
July 6, 2017Director590$132.61Sell$78,239.90
July 5, 2017Director3,490$131.12Sell$457,608.80
June 29, 2017CEO1,237$130.92Sell$161,948.04
June 23, 2017Director3,490$131.71Sell$459,667.90
June 22, 2017CEO1,234$132.32Sell$163,282.88
June 15, 2017CEO1,238$130.20Sell$161,187.60
June 8, 2017CEO1,240$129.60Sell$160,704.00
June 1, 2017CEO1,251$125.02Sell$156,400.02
May 25, 2017CEO1,265$119.40Sell$151,041.00
May 18, 2017CEO1,261$120.72Sell$152,227.92
May 11, 2017CEO1,259$122.00Sell$153,598.00
May 4, 2017CEO1,258$122.24Sell$153,777.92
April 27, 2017CEO1,262$120.78Sell$152,424.36
April 20, 2017CEO1,260$121.14Sell$152,636.40
April 13, 2017CEO1,258$122.12Sell$153,626.96
April 6, 2017CEO1,257$122.39Sell$153,844.23
March 30, 2017CEO1,230$134.56Sell$165,508.80
March 23, 2017CEO1,219$139.33Sell$169,843.27
March 22, 2017Director2,000$139.37Sell$278,740.00
March 16, 2017CEO1,218$140.16Sell$170,714.88
March 9, 2017CEO1,206$146.72Sell$176,944.32
March 2, 2017CEO1,203$148.49Sell$178,633.47
Feb. 23, 2017CEO1,208$145.16Sell$175,353.28
Feb. 16, 2017CEO1,173$167.92Sell$196,970.16
Jan. 12, 2017Director5,000$141.99Sell$709,950.00
Jan. 12, 2017CEO1,214$142.37Sell$172,837.18
Jan. 5, 2017CEO1,208$145.73Sell$176,041.84
Dec. 29, 2016CEO1,211$143.63Sell$173,935.93
Dec. 22, 2016CEO1,218$140.23Sell$170,800.14
Dec. 15, 2016CEO1,212$143.11Sell$173,449.32
Dec. 8, 2016CEO1,236$131.78Sell$162,880.08
Dec. 6, 2016Director5,000$133.37Sell$666,850.00
Dec. 1, 2016CEO1,246$126.86Sell$158,067.56
Nov. 25, 2016CEO1,233$132.81Sell$163,754.73
Nov. 17, 2016CEO1,232$132.94Sell$163,782.08
Nov. 10, 2016Director5,000$131.42Sell$657,100.00
Nov. 10, 2016CEO1,240$129.82Sell$160,976.80
Nov. 3, 2016CEO1,272$116.94Sell$148,747.68
Oct. 27, 2016CEO1,272$117.06Sell$148,900.32
Oct. 20, 2016CEO1,282$113.30Sell$145,250.60
Oct. 13, 2016CEO1,269$117.99Sell$149,729.31
Oct. 6, 2016CEO1,260$121.17Sell$152,674.20
Sept. 29, 2016CEO1,272$116.94Sell$148,747.68
Sept. 26, 2016Director1,291$125.57Sell$162,110.87
Sept. 22, 2016CEO1,249$125.87Sell$157,211.63
  • Insiders are both buying and selling United Therapeutics Corporation stock.

  • The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, Raymond Dwek, John Maxim Ferrari, Christopher Patusky, Paul Mahon, David Zaccardelli, Michael Benkowitz, Richard Giltner, Nilda Mesa, James Edgemond, Louis W Sullivan, Tommy G Thompson, Judy D Olian, Ray Kurzweil, Paul A. Mahon, Judy D. Olian, R Paul Gray, MAHON PAUL A, Louis Sullivan, Tommy G. Thompson, and DWEK RAYMOND

  • The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.

  • Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.

  • Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.

  • The most recent insider trade for United Therapeutics Corporation was on April 17, 2025.

  • The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.

  • The single biggest insider sell for United Therapeutics Corporation was from Louis W Sullivan with a total value of $9,781,722.98 on Dec. 18, 2024.